ERBB4 and bladder transitional cell carcinoma: Upregulation of ErbB4 and its ligands could promote the development of BLCA, and the co-expression of ErbB3 and ErbB4 has been reported to be associated with an improved survival time in BLCA patients (Memon et al., 2004).